Reviewing the evidence on effectiveness and cost-effectiveness of HIV prevention strategies in Thailand. Pattanaphesaj J, Teerawattananon Y.  Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Thailand Backgroud: Following universal access to antiretroviral

ISPOR 2008 International Fellowship Report: Is it Time to Think Seriously About Making HTA Available in Settings Where There is the Most Need? Yot Teerawattananon Health Intervention and Technology Assessment Program, Department of Health, Ministry of Public Health, Nonthaburi, Thailand Int

Stories of knowledge translation: lessons learned from three years of experience working in a policy research unit under the Thai Ministry of Public Health Jomkwan Yothasamut Health Intervention and Technology Assessment Program, Thai Ministry of Public Health Introduction Quality reseach ca

Government use licenses in Thailand: an assessment of the health and economic impacts Inthira Yamabhai, Adun Mohara, Sripen Tantivess*, Kakanang Chaisiri and Yot Teerawattananon. Health Intervention and Technology Assessment Program (HITAP) Background Between 2006 and 2008, Thailand’s Mi

Government use licenses in Thailand: The power of evidence, civil movement and political leadership Suwit Wibulpolprasert1, Vichai Chokevivat2, Cecilia Oh3 and Inthira Yamabhai3* 3Health Intervention and Technology Assessment Program Abstract This paper attempts to describe and analyse t

Is a HIV vaccine a viable option and at what price? An economic evaluation of adding HIV vaccination into existing prevention programs in Thailand Pattara Leelahavarong1*, Yot Teerawattananon1, Pitsaphun Werayingyong1, Chutima Akaleephan2, Nakorn Premsri3, Chawetsan Namwat3, Wiwat Peerapatanapoki

Economic Evaluation of Policy Options for Prevention and Control of Cervical Cancer in Thailand Naiyana Praditsitthikorn,1,2 Yot Teerawattananon,1,3 Sripen Tantivess,1,3 Supon Limwattananon,3 Arthorn Riewpaiboon,2 Saibua Chichareon,4 Nantakan Ieumwananonthachai5 and Viroj Tangcharoensathien3

Abstract: There is increasing impetus to use pharmaceutical interventions, ie, ranibizumab or bevacizumab, for the treatment of particular macular diseases. This paper describes the evidence and decision-making of the National List of Essential Medicines Committee that recently announced the inclusi

Inthira Yamabhai1,2* and Richard D Smith2 Abstract Background: Although it has been two decades since the Thai Patent Act was amended to comply with the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), there has been little emphasis given to assessing the implication

Systematic Review of Economic Evaluations of Preparedness Strategies and Interventions against Influenza Pandemics. Roma´n Pe´ rez Velasco1*, Naiyana Praditsitthikorn1, Kamonthip Wichmann1, Adun Mohara1, Surachai Kotirum1, Sripen Tantivess1, Constanza Vallenas2, Hande Harmanci2, Yot Teerawattanan